The developments come at a time when European banks are shelling out hefty sums as central counterparty exposures for dealing with the Clearing Corporation of India (CCIL), the RBI-supervised organisation which has found itself at the epicentre of the regulatory logjam between the Indian central bank and the ESMA.
Investors not inclined to ‘sell India buy China’ but to ‘sell India buy USA’: Samir Arora
Samir Arora cautioned investors not to get overly excited by CLSA’s increased allocation to India. He believes that investors were shifting to the US, not
November 16, 2024